Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-20
2008-09-30
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S279000, C544S321000
Reexamination Certificate
active
07429594
ABSTRACT:
The present invention relates to compounds having the general formulaor a pharmaceutically acceptable salt thereof, wherein R1is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1is additionally substituted; and R2is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
REFERENCES:
patent: 6096753 (2000-08-01), Spohr et al.
patent: WO 98/24780 (1998-06-01), None
patent: WO 98/24782 (1998-06-01), None
patent: WO 03/099808 (2003-12-01), None
Douglas, Jr., Introduction to Viral Diseases, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Gamaraschi et al., High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli, Biochimica et Biophysica Acta, 1736 (2005) pp. 136-143.
Casanova et al., PubMed Abstract (Rev Neurol. 28(9):909-15) May 1999.
Ben-Hur et al., Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells, Journal of Neuroimmunology 175 (2006) pp. 12-18.
Vuolteenaho et al., Effects of TNFalpha-antagonists on nitric oxide production in human cartilage, Osteoarthritis and Cartilage (2002) 10, pp. 327-332.
Meng, Inflammation in Atherosclerosis: New Opportunities for Drug Discover, Min-Reviews in Medicinal Chemistry, 2005, 5, pp. 33-40.
Bajpai Manoj
Liu Longbin
Lopez Patricia
Siegmund Aaron C.
Amgen Inc.
Prabhakar Reddy G.
Rao Deepak
LandOfFree
Substituted heterocyclic compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3976786